Top Markets
Coin of the day
BIOLASE, Inc. BIOLASE, Inc.

BIOLASE, Inc.

BIOL
Rang in Aktien #42643
BIOLASE, Inc., along with its various divisions, operates as a global... BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.
Aktienkurs
$0.00695
Zuletzt synchronisiert: 2024-10-29
Marktkapitalisierung
$536.40
Veränderung (1 Tag)
-0.71%
Veränderung (1 Jahr)
0.00%
Land
US
Handel BIOLASE, Inc. (BIOL)

Kategorie

Gewinn für BIOLASE, Inc. (BIOL)
Gewinn im Sep 2024 TTM: $-16.00M
Laut den aktuellen Finanzberichten von BIOLASE, Inc. betragen die aktuellen Gewinne des Unternehmens $-16.00M. Im Jahr 2022 erzielte das Unternehmen einen Gewinn von $-28.53M, ein Rückgang im Vergleich zu dem Gewinn im Jahr 2021, der $-16.09M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von BIOLASE, Inc. von 2000 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
2026 (TTM) $-16.00M -22.33%
2023 $-20.60M -27.78%
2022 $-28.53M 77.25%
2021 $-16.09M -3.64%
2020 $-16.70M -6.69%
2019 $-17.90M -16.57%
2018 $-21.45M 23.06%
2017 $-17.43M 14.54%
2016 $-15.22M -24.28%
2015 $-20.10M 6.84%
2014 $-18.81M 61.55%
2013 $-11.65M 295.45%
2012 $-2.95M -33.02%
2011 $-4.40M -63.25%
2010 $-11.96M 321.68%
2009 $-2.84M -68.51%
2008 $-9.01M 26.57%
2007 $-7.12M 57.21%
2006 $-4.53M -73.74%
2005 $-17.24M 95.90%
2004 $-8.80M -214.79%
2003 $7.67M 179.10%
2002 $2.75M -1,063.86%
2001 $-285.00K 0.00%
2000 0.00 0.00%
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
$7.51B -47,040.82%
US
$5.15B -32,272.99%
US
$5.56B -34,866.58%
IE
$3.86B -24,229.74%
US
$1.42B -8,959.45%
US